We are live on ! Find out more
Victory Capital Management

Victory Capital Management Portfolio holdings

AUM $178B
1-Year Est. Return 37.23%
This Fund
S&P 500
This Quarter Est. Return
+25.05%
1 Year Est. Return
+37.23%
3 Year Est. Return
+100.22%
5 Year Est. Return
+128.39%
10 Year Est. Return
+575.99%
AUM
$73.8B
AUM Growth
-$45B
Cap. Flow
-$66.7B
Cap. Flow %
-90.35%
Top 10 Hldgs %
9.43%
Holding
3,841
New
51
Increased
330
Reduced
2,079
Closed
1,309

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$1.36B
2
AAPL icon
Apple
AAPL
+$1.23B
3
AMZN icon
Amazon
AMZN
+$1.14B
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$628M
5
META icon
Meta Platforms (Facebook)
META
+$602M

Sector Composition

Rank Sector Weight
1 Technology 18.49%
2 Financials 12.19%
3 Healthcare 12.05%
4 Industrials 11.64%
5 Consumer Discretionary 10.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UROV
3601
DELISTED
Urovant Sciences Ltd.
UROV
-1,782
Closed -$16K
NEOS
3602
DELISTED
Neos Therapeutics, Inc
NEOS
-16,368
Closed -$12K
RLH
3603
DELISTED
Red Lions Hotel Corporation
RLH
-8,210
Closed -$12K
VIE
3604
DELISTED
Viela Bio, Inc. Common Stock
VIE
-4,944
Closed -$188K
PRGX
3605
DELISTED
PRGX Global, Inc.
PRGX
-7,446
Closed -$20K
SG
3606
DELISTED
Sirius International Insurance Group, Ltd. Common Share
SG
-1,598
Closed -$14K
ZAGG
3607
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
-8,666
Closed -$26K
TNAV
3608
DELISTED
Telenav Inc.
TNAV
-13,178
Closed -$56K
ARA
3609
DELISTED
American Renal Associates Holdings, Inc
ARA
-4,292
Closed -$28K
PRVL
3610
DELISTED
Prevail Therapeutics Inc. Common Stock
PRVL
-9,496
Closed -$116K
GV
3611
DELISTED
Goldfield Corporation
GV
-6,966
Closed -$20K
MVC
3612
DELISTED
MVC Capital, Inc.
MVC
-5,086
Closed -$22K
PRCP
3613
DELISTED
Perceptron Inc
PRCP
-2,992
Closed -$8K
RELV
3614
DELISTED
Reliv International Inc
RELV
-424
Closed -$2K
FRAN
3615
DELISTED
Francesca's Holdings Corporation
FRAN
-1,006
Closed -$2K
NTRP
3616
DELISTED
Neurotrope, Inc. Common
NTRP
-5,950
Closed -$4K
HUD
3617
DELISTED
Hudson Ltd. Class A Common Shares
HUD
-13,764
Closed -$70K
YGYI
3618
DELISTED
Youngevity International, Inc Common Stock
YGYI
-5,664
Closed -$4K
AMAG
3619
DELISTED
AMAG Pharmaceuticals
AMAG
-9,282
Closed -$58K
MR
3620
DELISTED
Montage Resources Corporation Common Stock
MR
-6,700
Closed -$16K
APEX
3621
DELISTED
Apex Global Brands Inc. Common Stock
APEX
-132
Closed
GARS
3622
DELISTED
Garrison Capital Inc.
GARS
-5,560
Closed -$10K
RST
3623
DELISTED
ROSETTA STONE INC
RST
-6,484
Closed -$90K
ONDK
3624
DELISTED
On Deck Capital, Inc.
ONDK
-15,180
Closed -$24K
AKCA
3625
DELISTED
Akcea Therapeutics Inc
AKCA
-2,448
Closed -$36K

Similar funds

Victory Capital Management's Q2 2020 Portfolio in Review

As of Q2 2020, Victory Capital Management held 3,841 positions worth $73.8B, down 38% from $119B the previous quarter. Its ten largest holdings account for 9.4% of the portfolio.

Victory Capital Management withdrew a net $66.7B in Q2 2020, closing 1,309 positions and reducing 2,079 holdings. Its most notable exit was AMES National, an estimated $91.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Victory Capital Management opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $170M.

  • Victory Capital Management's largest Q2 2020 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 1,558,761 shares worth $170M.
  • Victory Capital Management added most to Tyson Foods in Q2 2020, an estimated $184M increase.
  • Victory Capital Management's biggest Q2 2020 reduction was Microsoft, cutting an estimated $1.36B.
  • Victory Capital Management fully exited AMES National in Q2 2020, selling an estimated $91.4M.
  • Victory Capital Management's ten largest holdings make up 9.4% of its $73.8B portfolio in Q2 2020.
  • Victory Capital Management opened 51 new positions and closed 1,309 in Q2 2020.
  • Victory Capital Management's portfolio value fell 38% quarter-over-quarter to $73.8B.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.